Patent Family Strategy

A patent family is a group of patents and applications connected through shared priority and strategic use of US and international patent law: DEFINITION OF A PATENT FAMILY: a patent family consists of all patent applications and patents that claim priority to the same original ('parent') filing; the family may include: continuation applications (same disclosure; different claims); continuation-in-part (CIP) applications (adds new matter); divisional applications (split off from restricted applications); international applications (PCT; EP; CN; JP; KR; etc.) that claim priority to the US filing; WHY PATENT FAMILIES MATTER: COMPETITIVE COVERAGE: a single patent claim covers one specific implementation; a family of patents covers multiple implementations; as competitors design around one claim, a family can cover their design-around; ADAPTIVE PROSECUTION: the technology and competitive landscape change; a patent family allows prosecution to respond: new claims can be filed as continuations to cover newly discovered competitive products; claims can be narrowed if prior art threatens the broad claims while preserving the priority date; TERM MANAGEMENT: continuations filed close to the original filing date preserve nearly the same patent term (20 years from the original non-provisional); late-filed continuations burn more of the remaining term; INTERNATIONAL COORDINATION: US patents only cover the US market; a family with international branches can cover the key global markets where competitors manufacture or sell; LICENSING VALUE: patent families (vs. single patents) are generally more valuable in licensing negotiations because they provide redundant coverage (invalidating one claim does not eliminate all protection) and broader geographic reach; ACQUISITIONS: sophisticated acquirers (of patents or companies) analyze patent families to assess IP strength; a large, coherent family around a core technology is more valuable than isolated patents; THE FAMILY TREE: GRANDPARENT (earliest priority); PARENT (first actual non-provisional); CHILDREN (continuations; divisionals; CIPs filed while parent is pending); GRANDCHILDREN (continuations of continuations); the tree can extend for decades as long as at least one application remains pending.

Continuations are one of the most powerful tools in patent strategy: WHAT IS A CONTINUATION: a continuation application is a new patent application that claims priority to a parent application under 35 U.S.C. § 120; it uses the SAME specification as the parent (no new matter); it must be filed while the parent is still PENDING (before the parent issues or abandons); it can contain different claims — broader; narrower; or in a different claim category; REQUIREMENTS FOR A § 120 CONTINUATION: (1) COPENDING: the continuation must be filed while the parent is still pending (before it issues or is abandoned); (2) SAME DISCLOSURE: the continuation CANNOT add new subject matter (if you need to add new disclosure, file a CIP); (3) PRIORITY CLAIM: the continuation must specifically claim priority to the parent in the ADS; (4) SAME INVENTOR OR COMMON INVENTOR: at least one inventor from the parent must be included; STRATEGIC USES OF CONTINUATIONS: BROADENING AFTER ISSUANCE: after a patent issues, study it and file a continuation with BROADER claims while the parent is still pending; when the continuation issues, you have broader coverage without losing the original priority date; COVERING COMPETITOR PRODUCTS: after a competitor launches a product, analyze their implementation; if you can craft claims that cover their product and are supported by your original disclosure — file a continuation; NARROWING AFTER PRIOR ART APPEARS: if prior art surfaces that threatens the independent claims, file a continuation with narrower claims that are still over the prior art; this preserves the patent family while addressing validity risks; DIFFERENT CLAIM TYPES: if your parent has only system claims, file a continuation with method claims or CRM claims; PROSECUTION STRATEGY: if the parent examiner issues a final rejection that would require very narrow claims, file a continuation and pursue broader claims before a different examiner while keeping the parent pending with narrower claims; RCE vs. CONTINUATION: a Request for Continued Examination (RCE) continues prosecution IN the same application; a continuation is a NEW application; RCE is cheaper but gives up some strategic flexibility; continuations cost more but open new prosecution avenues; TIMING: the continuation must be filed BEFORE the parent issues; once the parent issues, no more continuations can be filed from it (only from other pending applications in the family).

A CIP adds new matter to the specification and has different effective filing dates for different claims: WHAT IS A CIP: a continuation-in-part (CIP) is an application that: (a) contains some subject matter disclosed in a parent application; AND (b) adds NEW MATTER not found in the parent application; the new matter gives the CIP a portion of the specification that is NOT present in the parent; EFFECTIVE FILING DATES IN A CIP — THE CRITICAL ISSUE: claims in the CIP that are FULLY SUPPORTED by the PARENT'S original disclosure get the PARENT'S filing date as their effective filing date; claims that require the NEW MATTER added in the CIP get the CIP'S FILING DATE as their effective filing date; this is strategically critical: public disclosures between the parent's filing date and the CIP's filing date are NOT prior art against claims fully supported by the parent; but they ARE prior art against claims that depend on the new matter; WHEN TO FILE A CIP: TECHNOLOGY EVOLUTION: the inventor has made improvements or new discoveries since the original filing; the new developments can be added to the CIP and claimed with the CIP's filing date; ADDING EXAMPLES OR DATA: the parent was filed with theoretical disclosure; actual experimental results can be added in a CIP to strengthen enablement and written description; CONTINUATION vs. CIP DECISION: if the new claim is fully supported by the ORIGINAL disclosure — file a CONTINUATION (keeps the original priority date for all claims); if the new claim requires ADDITIONAL technical content — file a CIP (new matter gets only the CIP date); DANGER OF CIPS: the CIP's claims to new matter have a LATER effective filing date; anything disclosed publicly between the parent and CIP filing dates is prior art against those claims; in a fast-moving field, a CIP can expose new claims to significant prior art; CIPS IN CONTINUATION CHAINS: a CIP can be the basis for FURTHER continuations; those further continuations can claim priority to BOTH the CIP and the original application (for claims supported by the original); the priority chain becomes complex and must be carefully tracked; CIPS vs. SEPARATE NEW APPLICATIONS: sometimes it is better to file a completely SEPARATE new application for the new technology rather than a CIP; a separate application has a clean record and can be independently licensed, sold, or enforced.

Divisionals arise from restriction requirements and require specific strategic planning: WHAT IS A DIVISIONAL: a divisional application is an application filed as a result of a USPTO RESTRICTION REQUIREMENT; it claims one of the inventions that was restricted out of the parent; WHY DIVISIONALS ARE FILED: the USPTO issues a restriction requirement when a patent application contains claims to multiple distinct inventions; the applicant must ELECT one invention to prosecute in the original application; the other inventions can be pursued in divisional applications; SAME PRIORITY DATE: divisional applications get the SAME priority date as the parent application (they arose from the parent disclosure); the parent and all divisionals share the same earliest effective filing date; DIVISIONAL STRATEGY: FILE ALL DIVISIONALS: once a restriction requirement issues, the applicant has the right to file divisional applications for each restricted-out group; do NOT let these divisional rights lapse; filing all divisionals is generally good strategy because: each restricted group represents a distinct patent with the same priority date; each divisional can be independently licensed; each divisional provides coverage from a different angle; TIMING: divisional applications must be filed while the parent (or another application in the family) is still pending; a divisional right does not extend indefinitely; if the parent issues, divisionals can still be filed from pending continuations that contain the parent's disclosure; PROSECUTION INDEPENDENCE: each divisional is prosecuted independently; the examiner in the parent application's rejection does not bind the divisional examiner; a restriction means the inventions were considered distinct — so divisionals should be allowed to prosecute on their own merits; DOUBLE PATENTING: because divisionals have the same disclosure as the parent, if both the parent and divisional issue with overlapping claims, one may receive an ODP rejection; divisional applications that claim the same subject as the parent must either differentiate or file a terminal disclaimer; ODP SAFE HARBOR FOR DIVISIONALS: § 121 provides a safe harbor against ODP rejections for claims directed to the restricted inventions; if the restriction was properly made and the divisional claims only the restricted-out group, ODP cannot be raised based on the parent/divisional relationship; this safe harbor is valuable and should be preserved by not combining restricted inventions back into the same application.

International patent strategy requires balancing coverage, cost, and competitive landscape: THE PCT ROUTE — THE MOST COMMON INTERNATIONAL STRATEGY: the Patent Cooperation Treaty (PCT) allows a single international application that: establishes a filing date effective in all 153+ member countries; provides an International Search Report (ISR) and Written Opinion (WO); gives 30 months (or 31 months in some countries) from the earliest priority date to enter national phases; PCT FILING TIMING: file the PCT application within 12 months of the US provisional or non-provisional filing date; this preserves the US priority date in all designated countries; PCT COSTS: ~$5,000-$15,000 for the PCT application itself (depending on claim count and applicant size); national phase entry fees add $2,000-$10,000 per country (plus local counsel fees); NATIONAL PHASE ENTRY DECISION — WHERE TO FILE: enter national phase in countries where: COMPETITORS MANUFACTURE their competing products; KEY MARKETS for the patented technology exist; LICENSEES will need protection; HIGH-VALUE IP MARKETS: US; Europe (EPO); China (CNIPA); Japan (JPO); Korea (KIPO); are typically highest priority; India; Canada; Australia; Brazil are often secondary; EUROPEAN PATENT STRATEGY: a single EP (European Patent Office) application covers 38 EPC member states; once issued, the EP patent must be validated in each country where protection is sought (validation fees + local translation costs in some countries); the Unitary Patent covers 18 EU member states with a single validation; CHINA STRATEGY: China has become one of the most important patent jurisdictions; Chinese competitors manufacture competing products; filing in China is now routine for technology companies; CLAIM STRATEGY BY COUNTRY: the US allows broad functional claims; some countries (Germany; Japan) prefer more structural claims; EP examines claims differently (e.g., method claims in EU have different considerations); file different claim sets optimized for each jurisdiction; ISR USE IN PROSECUTION: the PCT International Search Report (ISR) and WO provide examiner feedback BEFORE national phase entry; if the ISR finds damaging prior art, the applicant can use the 30-month window to refine claims before expensive national phase fees are due; FAMILY COORDINATION: keep track of all family members; file continuations that claim priority to the PCT; international applications can have US national phase applications (§ 371 applications) which can then spawn US continuations.